Gnetin-C is a naturally occurring stilbene derived from the seeds of Gnetum gnemon L., an edible plant native to Southeast Asia that is called melinjo. Although the biological properties and safety of G. gnemon extract, which contains nearly 3% Gnetin-C, have been confirmed in various human studies, whether or not pure Gnetin-C is safe for humans is unclear at present. We conducted a randomized, double-blind, placebo-controlled trial. Healthy subjects were randomly divided into two groups. The interventional group (n = 6) was given Gnetin-C, and the control group (n = 6) was provided a placebo, for 14 days. Lipid profiles, biomarkers of oxidative stress and circulating blood cells were assessed before and after the intervention. All subjects completed the study, with no side effects reported across the study duration. Gnetin-C supplementation demonstrated a statistically significant increase in the absolute number of circulating natural killer (NK) cells expressing the activating receptors NKG2D and NKp46. NK cells derived from subjects who received Gnetin-C for two weeks showed higher cytotoxicity against K562 target cells than those before receiving Gnetin-C. In addition, Gnetin-C also resulted in a significant decrease in the absolute neutrophil count in the blood compared with the placebo. Furthermore, Gnetin-C significantly reduced the levels of uric acid, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, total adiponectin, and high-molecular-weight adiponectin. These data indicate that Gnetin-C has biological effects of enhancing the NK activity on circulating human immune cells. The immunomodulatory effects are consistent with a putative improvement in cancer immunosurveillance via the upregulation of the NKG2D receptor. The study was registered with UMIN-CTR, number 000030364, on 12 December 2017.
1 July 2020 in Colloids and Surfaces A: Physicochemical and Engineering Aspects
The prognosis of multiple myeloma (MM) has drastically improved owing to the development of new drugs, such as proteasome inhibitors and immunomodulatory drugs. Nevertheless, MM is an extremely challenging disease, and many patients are still refractory to the existing therapies, thus requiring new treatment alternatives. Venetoclax is a selective, orally bioavailable inhibitor of BCL-2 that shows efficacy in MM not only as a single agent but also in combination therapy, especially for MM patients with translocation t(11;14). However, many patients are refractory to this drug. Here, we treated the MM cell lines KMS12PE and KMS27 with a combination treatment of venetoclax targeting BCL-2 and daratumumab targeting CD38 to evaluate the synergistic cytotoxicity of these drugs in vitro. MM cell lines were co-cultured with natural killer (NK) cells at an effector:target ratio of 0.3:1 in the presence of serial concentrations of daratumumab and venetoclax, and the resulting apoptotic MM cells were detected by flow cytometry using annexin V. These results indicated that the antibody-dependent cell-mediated NK cytotoxicity was enhanced in KMS12PE and KMS27 cells harboring t(11;14) with a high BCL-2 expression, suggesting that the combination treatment of venetoclax and daratumumab should be especially effective in patients with these characteristics.
In general, dewatering of plant tissues (such as vegetables) and food materials is achieved by heating. In order to prevent the degradation of biologically active components in plant materials, the dewatering process should be carried out at low temperature. Therefore, in the present study, we attempted to develop a simple protocol for dewatering cryo-preserved plant tissues using liquefied dimethyl ether (DME). Prior to dewatering from frozen plant materials, we have examined the efficiency of liquefied DME for cryogenic removal of water from ice cubes. Here, lemon peel residue (consisting of flavedo and albedo) was chosen as the model plant material for dewatering and concomitant extractions of water-soluble components such as ascorbate and citric acid and hydrophobic components, chiefly, essential oils (EOs). By focusing on the exploitation of unused resources after food processing, the juice extraction residues from lemon fruits (lemon peels) were used as the starting materials. The yield of vitamin C (VC) extracted from the peel tissues derived from a single lemon fruit exceeded the amount of VC found in the manually press-extracted juice from a single lemon fruit. The major components in DME-extracted crude lemon EOs were determined and quantified with gas chromatography-mass spectrometry (GC-MS) and gas chromatography-flame ionization detector (GC-FID) to be limonene (40.4%, w/w), β-pinene (10.4%, w/w), and γ-terpinene (6.9 %, w/w).
15 January 2020 in Colloids and Surfaces A: Physicochemical and Engineering Aspects